Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC
Clinical trial NCT07040072 · RECRUITING
Trial details
- NCT number
- NCT07040072
- Sponsor
- Beijing Tongren Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-09
- Primary completion
- 2027-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.